Trastuzumab Deruxtecan in Previously Treated HER2-Low Advanced Breast Cancer
Original Article
S. Modi, W. Jacot, T. Yamashita, J. Sohn, M. Vidal, E. Tokunaga, J. Tsurutani, N.T. Ueno, A. Prat, Y.S. Chae, K.S. Lee, N. Niikura, Y.H. Park, B. Xu, X. Wang, M. Gil-Gil, W. Li, J.-Y. Pierga, S.-A. Im, H.C. Moore, H.S. Rugo, R. Yerushalmi, F. Zagouri, A. Gombos, S.-B. Kim, Q. Liu, T. Luo, C. Saura, P. Schmid, T. Sun, D. Gambhire, L. Yung, Y. Wang, J. Singh, P. Vitazka, G. Meinhardt, N. Harbeck, and D.A. Cameron
N Engl J Med 2022;387:9-20
Course summary
Available credit:
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course opens:
07/06/2022
Course expires:
07/07/2024
Available Credit
- 1.00 AMA PRA Category 1 Credit™
- 1.00 Participation
Course closed
This course closed on Sunday, July 7, 2024 - 11:59pm.

Facebook
X
LinkedIn
Forward